Lizzy,
See my post 414421: Ziploc,
EXECUTIVE SUMMARY
Based on 9 U.S. Provisional Patent Applications, Amarin has secured a worldwide patent priority claim to a lymph-releasing composition of eicosapentaenoic acid ethyl ester (LR-EtEPA) technology/invention and methods of using the same to increase EPA uptake in tissues to treat and/or prevent the onset of a number of diseases including:
- Cardiopulmonary, cardiovascular, and cerebrovascular diseases
- Pulmonary disease including sepsis, SIRS, and/or ARDS
- Neurological diseases
- Cancer
- Diseases associated with the kidneys, pancreas, liver, intestines, blood cells, lymph, and the musculoskeletal system
- Diseases associated with oxidative stress and/or glutathione (GSH) depletion
- Inflammation and diseases induced by air pollution
ETC.......